PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30918945-6	2019	RESULTS: Although butyrate promoted Th1 cell development by promoting IFN-gamma and T-bet expression, it inhibited Th17 cell development by suppressing IL-17, Roralpha, and Rorgammat expression.	Butyrates	18-26	interferon gamma	Mus musculus	70-79	
30918945-6	2019	RESULTS: Although butyrate promoted Th1 cell development by promoting IFN-gamma and T-bet expression, it inhibited Th17 cell development by suppressing IL-17, Roralpha, and Rorgammat expression.	Butyrates	18-26	T-box 21	Mus musculus	84-89	
30918945-6	2019	RESULTS: Although butyrate promoted Th1 cell development by promoting IFN-gamma and T-bet expression, it inhibited Th17 cell development by suppressing IL-17, Roralpha, and Rorgammat expression.	Butyrates	18-26	RAR-related orphan receptor alpha	Mus musculus	159-167	
30918945-7	2019	Interestingly, butyrate upregulated IL-10 production in T cells both under Th1 and Th17 cell conditions.	Butyrates	15-23	interleukin 10	Mus musculus	36-41	
30918945-8	2019	Furthermore, butyrate induced T-cell B-lymphocyte-induced maturation protein 1 (Blimp1) expression, and deficiency of Blimp1 in T cells impaired the butyrate upregulation of IL-10 production, indicating that butyrate promotes T-cell IL-10 production at least partially through Blimp1.	Butyrates	13-21	PR domain containing 1, with ZNF domain	Mus musculus	37-78	
30918945-8	2019	Furthermore, butyrate induced T-cell B-lymphocyte-induced maturation protein 1 (Blimp1) expression, and deficiency of Blimp1 in T cells impaired the butyrate upregulation of IL-10 production, indicating that butyrate promotes T-cell IL-10 production at least partially through Blimp1.	Butyrates	13-21	PR domain containing 1, with ZNF domain	Mus musculus	80-86	
30918945-8	2019	Furthermore, butyrate induced T-cell B-lymphocyte-induced maturation protein 1 (Blimp1) expression, and deficiency of Blimp1 in T cells impaired the butyrate upregulation of IL-10 production, indicating that butyrate promotes T-cell IL-10 production at least partially through Blimp1.	Butyrates	149-157	PR domain containing 1, with ZNF domain	Mus musculus	118-124	
30918945-8	2019	Furthermore, butyrate induced T-cell B-lymphocyte-induced maturation protein 1 (Blimp1) expression, and deficiency of Blimp1 in T cells impaired the butyrate upregulation of IL-10 production, indicating that butyrate promotes T-cell IL-10 production at least partially through Blimp1.	Butyrates	149-157	interleukin 10	Mus musculus	174-179	
30918945-8	2019	Furthermore, butyrate induced T-cell B-lymphocyte-induced maturation protein 1 (Blimp1) expression, and deficiency of Blimp1 in T cells impaired the butyrate upregulation of IL-10 production, indicating that butyrate promotes T-cell IL-10 production at least partially through Blimp1.	Butyrates	149-157	PR domain containing 1, with ZNF domain	Mus musculus	118-124	
30918945-8	2019	Furthermore, butyrate induced T-cell B-lymphocyte-induced maturation protein 1 (Blimp1) expression, and deficiency of Blimp1 in T cells impaired the butyrate upregulation of IL-10 production, indicating that butyrate promotes T-cell IL-10 production at least partially through Blimp1.	Butyrates	149-157	PR domain containing 1, with ZNF domain	Mus musculus	118-124	
30918945-8	2019	Furthermore, butyrate induced T-cell B-lymphocyte-induced maturation protein 1 (Blimp1) expression, and deficiency of Blimp1 in T cells impaired the butyrate upregulation of IL-10 production, indicating that butyrate promotes T-cell IL-10 production at least partially through Blimp1.	Butyrates	149-157	interleukin 10	Mus musculus	174-179	
30918945-8	2019	Furthermore, butyrate induced T-cell B-lymphocyte-induced maturation protein 1 (Blimp1) expression, and deficiency of Blimp1 in T cells impaired the butyrate upregulation of IL-10 production, indicating that butyrate promotes T-cell IL-10 production at least partially through Blimp1.	Butyrates	149-157	PR domain containing 1, with ZNF domain	Mus musculus	118-124	
30918945-9	2019	Rag1-/- mice transferred with butyrate-treated T cells demonstrated less severe colitis, compared with transfer of untreated T cells, and administration of anti-IL-10R antibody exacerbated colitis development in Rag-/- mice that had received butyrate-treated T cells.	Butyrates	30-38	recombination activating 1	Mus musculus	0-4	
30918945-9	2019	Rag1-/- mice transferred with butyrate-treated T cells demonstrated less severe colitis, compared with transfer of untreated T cells, and administration of anti-IL-10R antibody exacerbated colitis development in Rag-/- mice that had received butyrate-treated T cells.	Butyrates	242-250	interleukin 10 receptor, alpha	Mus musculus	161-167	
30918945-11	2019	CONCLUSIONS: These data indicate that butyrate controls the capacity of T cells in the induction of colitis by differentially regulating Th1 and Th17 cell differentiation and promoting IL-10 production, providing insights into butyrate as a potential therapeutic for the treatment of inflammatory bowel disease.	Butyrates	38-46	interleukin 10	Mus musculus	185-190	
30918945-11	2019	CONCLUSIONS: These data indicate that butyrate controls the capacity of T cells in the induction of colitis by differentially regulating Th1 and Th17 cell differentiation and promoting IL-10 production, providing insights into butyrate as a potential therapeutic for the treatment of inflammatory bowel disease.	Butyrates	227-235	interleukin 10	Mus musculus	185-190